vs
Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.
Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $43.5M, roughly 1.7× DYNEX CAPITAL INC). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 6.7%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs 4.6%).
Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
DX vs EOLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $43.5M | $73.1M |
| Net Profit | — | $-10.7M |
| Gross Margin | — | 66.9% |
| Operating Margin | — | 23.8% |
| Net Margin | — | -14.6% |
| Revenue YoY | 531.3% | 6.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $1.59 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $73.1M | ||
| Q4 25 | $43.5M | $90.3M | ||
| Q3 25 | $30.6M | $69.0M | ||
| Q2 25 | $23.1M | $69.4M | ||
| Q1 25 | $17.1M | $68.5M | ||
| Q4 24 | — | $78.9M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $66.9M |
| Q1 26 | — | $-10.7M | ||
| Q4 25 | — | $130.0K | ||
| Q3 25 | $150.4M | $-15.7M | ||
| Q2 25 | $-13.6M | $-17.1M | ||
| Q1 25 | $-3.1M | $-18.9M | ||
| Q4 24 | — | $-6.8M | ||
| Q3 24 | — | $-19.2M | ||
| Q2 24 | — | $-11.3M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 65.7% | ||
| Q3 25 | — | 66.5% | ||
| Q2 25 | — | 65.3% | ||
| Q1 25 | — | 68.1% | ||
| Q4 24 | — | 66.7% | ||
| Q3 24 | — | 68.9% | ||
| Q2 24 | — | 70.3% |
| Q1 26 | — | 23.8% | ||
| Q4 25 | — | 4.7% | ||
| Q3 25 | — | -16.7% | ||
| Q2 25 | — | -14.7% | ||
| Q1 25 | — | -22.1% | ||
| Q4 24 | — | -2.9% | ||
| Q3 24 | — | -25.3% | ||
| Q2 24 | — | -11.5% |
| Q1 26 | — | -14.6% | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | 491.3% | -22.8% | ||
| Q2 25 | -58.8% | -24.7% | ||
| Q1 25 | -18.0% | -27.6% | ||
| Q4 24 | — | -8.6% | ||
| Q3 24 | — | -31.4% | ||
| Q2 24 | — | -17.0% |
| Q1 26 | — | $-0.16 | ||
| Q4 25 | $1.59 | $0.01 | ||
| Q3 25 | $1.08 | $-0.24 | ||
| Q2 25 | $-0.14 | $-0.27 | ||
| Q1 25 | $-0.06 | $-0.30 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | — | $-0.30 | ||
| Q2 24 | — | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $531.0M | $49.8M |
| Total DebtLower is stronger | — | $156.4M |
| Stockholders' EquityBook value | $2.5B | — |
| Total Assets | $17.3B | $220.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $49.8M | ||
| Q4 25 | $531.0M | $53.8M | ||
| Q3 25 | $491.0M | $43.5M | ||
| Q2 25 | $387.5M | $61.7M | ||
| Q1 25 | $327.4M | $67.9M | ||
| Q4 24 | — | $87.0M | ||
| Q3 24 | — | $85.0M | ||
| Q2 24 | — | $93.7M |
| Q1 26 | — | $156.4M | ||
| Q4 25 | — | $146.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $121.8M | ||
| Q4 24 | — | $121.5M | ||
| Q3 24 | — | $121.2M | ||
| Q2 24 | — | $120.9M |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $-23.1M | ||
| Q3 25 | $2.0B | $-28.8M | ||
| Q2 25 | $1.6B | $-18.7M | ||
| Q1 25 | $1.4B | $-6.6M | ||
| Q4 24 | — | $5.5M | ||
| Q3 24 | — | $5.9M | ||
| Q2 24 | — | $19.3M |
| Q1 26 | — | $220.6M | ||
| Q4 25 | $17.3B | $225.9M | ||
| Q3 25 | $14.2B | $219.0M | ||
| Q2 25 | $11.3B | $228.8M | ||
| Q1 25 | $9.0B | $213.4M | ||
| Q4 24 | — | $232.6M | ||
| Q3 24 | — | $229.6M | ||
| Q2 24 | — | $233.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 22.00× | ||
| Q3 24 | — | 20.58× | ||
| Q2 24 | — | 6.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $120.8M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $120.8M | $12.8M | ||
| Q3 25 | $68.3M | $-14.7M | ||
| Q2 25 | $31.9M | $-24.8M | ||
| Q1 25 | $6.4M | $-15.6M | ||
| Q4 24 | — | $4.8M | ||
| Q3 24 | — | $-5.7M | ||
| Q2 24 | — | $-6.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $11.3M | ||
| Q3 25 | — | $-15.6M | ||
| Q2 25 | — | $-25.5M | ||
| Q1 25 | — | $-16.0M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | — | $-6.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.6% | ||
| Q3 25 | — | -22.7% | ||
| Q2 25 | — | -36.7% | ||
| Q1 25 | — | -23.3% | ||
| Q4 24 | — | 5.5% | ||
| Q3 24 | — | -9.9% | ||
| Q2 24 | — | -10.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 98.67× | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DX
Segment breakdown not available.
EOLS
| Product revenue, net | $72.7M | 99% |
| Service revenue | $390.0K | 1% |